Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Generex Biotechnology, a developer of drug delivery systems and technologies, has received two new patents, one in Mexico issued by the Mexican Institute of Industrial Property, the other in New Zealand issued by the Intellectual Property Office of New Zealand.
Subscribe to our email newsletter
The new patents contain claims to a pharmaceutical composition for pain relief containing a narcotic analgesic in micellar form.
Rose Perri, COO of Generex, said: “We are pleased that our patent portfolio is expanding to include the pain relief application. As we continue the pivotal Phase III studies of our flagship product, Generex Oral-lyn, we seek additional applications for our proprietary drug platform technology.”